 Paco Herson
Concepts (497)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Ischemia | 37 | 2026 | 362 | 9.490 |
Why?
| | TRPM Cation Channels | 12 | 2024 | 74 | 5.050 |
Why?
| | Heart Arrest | 26 | 2026 | 410 | 4.990 |
Why?
| | Stroke | 23 | 2025 | 1283 | 3.380 |
Why?
| | Hippocampus | 24 | 2026 | 986 | 3.150 |
Why?
| | Neuroprotective Agents | 16 | 2020 | 146 | 2.820 |
Why?
| | Neurons | 31 | 2023 | 1663 | 2.820 |
Why?
| | Cardiopulmonary Resuscitation | 16 | 2025 | 334 | 2.480 |
Why?
| | Sex Characteristics | 16 | 2024 | 798 | 2.120 |
Why?
| | Cell Death | 16 | 2021 | 379 | 1.950 |
Why?
| | Purkinje Cells | 7 | 2019 | 65 | 1.900 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 7 | 2024 | 199 | 1.660 |
Why?
| | Recovery of Function | 6 | 2025 | 721 | 1.610 |
Why?
| | Mice, Inbred C57BL | 49 | 2025 | 6021 | 1.550 |
Why?
| | CA1 Region, Hippocampal | 7 | 2024 | 49 | 1.500 |
Why?
| | Animals | 99 | 2026 | 38030 | 1.320 |
Why?
| | Mice | 66 | 2026 | 18266 | 1.300 |
Why?
| | Gonadal Steroid Hormones | 5 | 2025 | 143 | 1.300 |
Why?
| | Androgens | 8 | 2014 | 179 | 1.270 |
Why?
| | Long-Term Potentiation | 9 | 2026 | 206 | 1.190 |
Why?
| | Ischemia | 5 | 2022 | 421 | 1.110 |
Why?
| | Neuroprotection | 3 | 2020 | 46 | 1.080 |
Why?
| | Receptors, GABA-A | 5 | 2024 | 138 | 1.070 |
Why?
| | Disease Models, Animal | 25 | 2026 | 4565 | 1.050 |
Why?
| | Peptide Fragments | 2 | 2021 | 693 | 0.970 |
Why?
| | Signal Transduction | 11 | 2024 | 5234 | 0.930 |
Why?
| | Infarction, Middle Cerebral Artery | 12 | 2023 | 41 | 0.900 |
Why?
| | Poly(ADP-ribose) Polymerases | 4 | 2013 | 88 | 0.860 |
Why?
| | Hypothermia, Induced | 3 | 2016 | 96 | 0.830 |
Why?
| | Reperfusion Injury | 8 | 2020 | 300 | 0.830 |
Why?
| | Neuronal Plasticity | 9 | 2026 | 311 | 0.800 |
Why?
| | Small-Conductance Calcium-Activated Potassium Channels | 5 | 2014 | 13 | 0.790 |
Why?
| | Male | 73 | 2026 | 73014 | 0.790 |
Why?
| | Calcium | 10 | 2022 | 1181 | 0.770 |
Why?
| | Cognition | 4 | 2026 | 1286 | 0.750 |
Why?
| | Brain Injuries | 5 | 2021 | 499 | 0.700 |
Why?
| | Brain | 13 | 2024 | 2981 | 0.690 |
Why?
| | Brain Injuries, Traumatic | 4 | 2023 | 459 | 0.690 |
Why?
| | Thrombosis | 3 | 2022 | 397 | 0.680 |
Why?
| | Patch-Clamp Techniques | 13 | 2019 | 288 | 0.670 |
Why?
| | Excitatory Postsynaptic Potentials | 3 | 2016 | 119 | 0.640 |
Why?
| | Brain-Derived Neurotrophic Factor | 5 | 2026 | 155 | 0.640 |
Why?
| | Sex Factors | 11 | 2024 | 2101 | 0.640 |
Why?
| | Cerebellum | 4 | 2011 | 225 | 0.610 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 4 | 2020 | 233 | 0.610 |
Why?
| | Pregnanolone | 2 | 2011 | 34 | 0.600 |
Why?
| | Oligodendrocyte Precursor Cells | 2 | 2019 | 29 | 0.590 |
Why?
| | Potassium Channels | 8 | 2003 | 148 | 0.590 |
Why?
| | Nogo Proteins | 1 | 2019 | 10 | 0.580 |
Why?
| | Estradiol | 5 | 2018 | 517 | 0.580 |
Why?
| | Oligodendroglia | 3 | 2023 | 198 | 0.550 |
Why?
| | Neural Inhibition | 3 | 2024 | 180 | 0.540 |
Why?
| | Nerve Regeneration | 1 | 2018 | 57 | 0.530 |
Why?
| | Adult Stem Cells | 1 | 2018 | 39 | 0.530 |
Why?
| | Long-Term Synaptic Depression | 2 | 2018 | 49 | 0.510 |
Why?
| | Guideline Adherence | 1 | 2022 | 585 | 0.510 |
Why?
| | Estrogens | 5 | 2013 | 364 | 0.500 |
Why?
| | White Matter | 1 | 2019 | 169 | 0.490 |
Why?
| | Nervous System Diseases | 1 | 2019 | 286 | 0.480 |
Why?
| | Neurogenesis | 1 | 2018 | 158 | 0.470 |
Why?
| | Clotrimazole | 2 | 2013 | 3 | 0.470 |
Why?
| | Cerebrovascular Disorders | 2 | 2024 | 103 | 0.470 |
Why?
| | Cognitive Dysfunction | 2 | 2019 | 479 | 0.470 |
Why?
| | Neural Stem Cells | 1 | 2018 | 167 | 0.470 |
Why?
| | Mice, Knockout | 11 | 2021 | 3121 | 0.460 |
Why?
| | Aging | 3 | 2019 | 1983 | 0.450 |
Why?
| | Female | 44 | 2025 | 79080 | 0.450 |
Why?
| | Sirtuin 2 | 1 | 2015 | 27 | 0.450 |
Why?
| | Membrane Glycoproteins | 1 | 2018 | 495 | 0.440 |
Why?
| | Microglia | 5 | 2018 | 285 | 0.440 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 429 | 0.430 |
Why?
| | Emergency Medical Services | 1 | 2022 | 680 | 0.420 |
Why?
| | Cell Culture Techniques | 3 | 2013 | 371 | 0.420 |
Why?
| | Cell Hypoxia | 4 | 2013 | 247 | 0.420 |
Why?
| | Oxygen | 4 | 2012 | 996 | 0.410 |
Why?
| | Tissue Plasminogen Activator | 3 | 2022 | 244 | 0.410 |
Why?
| | Animal Experimentation | 1 | 2014 | 8 | 0.410 |
Why?
| | Kynurenine | 2 | 2025 | 114 | 0.410 |
Why?
| | Models, Animal | 2 | 2013 | 386 | 0.400 |
Why?
| | Inhibitory Postsynaptic Potentials | 2 | 2011 | 47 | 0.400 |
Why?
| | Naltrexone | 1 | 2015 | 114 | 0.390 |
Why?
| | Rats | 18 | 2023 | 5574 | 0.390 |
Why?
| | Age Factors | 6 | 2021 | 3321 | 0.370 |
Why?
| | Potassium Channels, Voltage-Gated | 2 | 2003 | 54 | 0.370 |
Why?
| | Cerebral Cortex | 3 | 2021 | 481 | 0.370 |
Why?
| | Cell Proliferation | 2 | 2019 | 2497 | 0.360 |
Why?
| | Ion Channels | 4 | 2004 | 128 | 0.360 |
Why?
| | Peptides | 3 | 2023 | 991 | 0.350 |
Why?
| | Memory | 4 | 2026 | 298 | 0.350 |
Why?
| | Magnetic Fields | 3 | 2022 | 24 | 0.340 |
Why?
| | Receptors, AMPA | 3 | 2026 | 147 | 0.330 |
Why?
| | Synapses | 4 | 2021 | 447 | 0.310 |
Why?
| | Hydrogen Peroxide | 4 | 2020 | 337 | 0.310 |
Why?
| | Oxidative Stress | 7 | 2020 | 1367 | 0.300 |
Why?
| | Action Potentials | 7 | 2022 | 498 | 0.300 |
Why?
| | Progesterone | 3 | 2010 | 214 | 0.300 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 3 | 2014 | 28 | 0.300 |
Why?
| | Dexmedetomidine | 3 | 2014 | 47 | 0.290 |
Why?
| | Immunohistochemistry | 7 | 2016 | 1709 | 0.280 |
Why?
| | Cells, Cultured | 10 | 2018 | 4112 | 0.280 |
Why?
| | Calcium Channels, T-Type | 2 | 2022 | 104 | 0.280 |
Why?
| | Rats, Sprague-Dawley | 9 | 2023 | 2533 | 0.280 |
Why?
| | Ion Channel Gating | 6 | 2004 | 94 | 0.270 |
Why?
| | Drug Delivery Systems | 2 | 2022 | 377 | 0.270 |
Why?
| | Glucose | 7 | 2014 | 1051 | 0.270 |
Why?
| | NAD | 2 | 1999 | 80 | 0.260 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 1148 | 0.260 |
Why?
| | Sepsis | 3 | 2019 | 668 | 0.260 |
Why?
| | HEK293 Cells | 3 | 2020 | 746 | 0.260 |
Why?
| | Memory Disorders | 2 | 2019 | 197 | 0.250 |
Why?
| | Humans | 36 | 2025 | 145625 | 0.250 |
Why?
| | Brain Infarction | 3 | 2016 | 23 | 0.250 |
Why?
| | Time Factors | 12 | 2025 | 7079 | 0.240 |
Why?
| | Tryptophan | 2 | 2025 | 183 | 0.240 |
Why?
| | Colloids | 2 | 2017 | 59 | 0.240 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2019 | 2018 | 0.240 |
Why?
| | Dihydrotestosterone | 5 | 2013 | 40 | 0.230 |
Why?
| | Protective Agents | 2 | 2019 | 43 | 0.220 |
Why?
| | Paraplegia | 2 | 2015 | 60 | 0.200 |
Why?
| | Olfactory Receptor Neurons | 1 | 2004 | 42 | 0.200 |
Why?
| | Myelin Proteins | 3 | 2016 | 45 | 0.200 |
Why?
| | Oxidants | 2 | 2020 | 100 | 0.200 |
Why?
| | GABAergic Neurons | 1 | 2024 | 37 | 0.200 |
Why?
| | Military Personnel | 2 | 2023 | 715 | 0.200 |
Why?
| | Receptors, Adrenergic, alpha-2 | 2 | 2013 | 11 | 0.200 |
Why?
| | Epoxide Hydrolases | 2 | 2013 | 13 | 0.200 |
Why?
| | Glycosaminoglycans | 1 | 2023 | 79 | 0.200 |
Why?
| | Calmodulin | 2 | 2019 | 70 | 0.200 |
Why?
| | Spinocerebellar Degenerations | 1 | 2003 | 7 | 0.190 |
Why?
| | Potassium Channels, Calcium-Activated | 4 | 2004 | 11 | 0.190 |
Why?
| | Smell | 1 | 2004 | 129 | 0.190 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2023 | 32 | 0.190 |
Why?
| | Orchiectomy | 3 | 2013 | 72 | 0.190 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 2 | 2013 | 55 | 0.190 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2023 | 64 | 0.190 |
Why?
| | Corpus Striatum | 4 | 2016 | 181 | 0.190 |
Why?
| | Spinal Cord Ischemia | 2 | 2013 | 60 | 0.190 |
Why?
| | Pneumonia | 2 | 2021 | 633 | 0.190 |
Why?
| | Behavior, Animal | 3 | 2018 | 530 | 0.180 |
Why?
| | Spinal Cord | 3 | 2014 | 378 | 0.180 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2023 | 80 | 0.180 |
Why?
| | Blood-Brain Barrier | 2 | 2022 | 167 | 0.180 |
Why?
| | Primary Cell Culture | 2 | 2013 | 172 | 0.180 |
Why?
| | Cerebral Infarction | 1 | 2022 | 46 | 0.180 |
Why?
| | Emergency Medical Dispatch | 1 | 2022 | 4 | 0.180 |
Why?
| | Cerebrovascular Circulation | 1 | 2024 | 293 | 0.180 |
Why?
| | Myelin Sheath | 3 | 2023 | 166 | 0.180 |
Why?
| | Phosphorylation | 4 | 2023 | 1717 | 0.170 |
Why?
| | Information Systems | 1 | 2022 | 58 | 0.170 |
Why?
| | Plasminogen | 1 | 2021 | 26 | 0.170 |
Why?
| | Metabolomics | 2 | 2024 | 737 | 0.170 |
Why?
| | Receptors, Androgen | 3 | 2013 | 149 | 0.170 |
Why?
| | Benzimidazoles | 2 | 2014 | 189 | 0.170 |
Why?
| | Blotting, Western | 5 | 2012 | 1176 | 0.170 |
Why?
| | Heroin | 1 | 2021 | 30 | 0.170 |
Why?
| | Organ Culture Techniques | 1 | 2021 | 150 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 366 | 0.170 |
Why?
| | Cell Survival | 6 | 2020 | 1102 | 0.170 |
Why?
| | Spinal Cord Injuries | 2 | 2015 | 238 | 0.170 |
Why?
| | Encephalitis | 2 | 2014 | 142 | 0.160 |
Why?
| | Presynaptic Terminals | 1 | 2021 | 89 | 0.160 |
Why?
| | Eclampsia | 1 | 2020 | 6 | 0.160 |
Why?
| | Islets of Langerhans | 2 | 1997 | 852 | 0.160 |
Why?
| | Metabolome | 1 | 2024 | 390 | 0.160 |
Why?
| | Insulinoma | 2 | 1997 | 30 | 0.160 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2017 | 195 | 0.160 |
Why?
| | Cell-Derived Microparticles | 1 | 2021 | 73 | 0.160 |
Why?
| | Extinction, Psychological | 1 | 2021 | 93 | 0.160 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 251 | 0.160 |
Why?
| | Death-Associated Protein Kinases | 1 | 2020 | 10 | 0.150 |
Why?
| | Adaptation, Physiological | 1 | 2004 | 567 | 0.150 |
Why?
| | Thalamus | 1 | 2021 | 132 | 0.150 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 55 | 0.150 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 25 | 0.150 |
Why?
| | Fibrinolysis | 2 | 2021 | 161 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 973 | 0.150 |
Why?
| | Cell Membrane | 2 | 2003 | 701 | 0.150 |
Why?
| | Inhibitory Concentration 50 | 1 | 2019 | 90 | 0.150 |
Why?
| | Intravital Microscopy | 1 | 2019 | 23 | 0.150 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2020 | 59 | 0.150 |
Why?
| | Models, Theoretical | 1 | 2023 | 558 | 0.150 |
Why?
| | Optical Imaging | 1 | 2019 | 63 | 0.150 |
Why?
| | Insulin | 3 | 1999 | 2524 | 0.150 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2019 | 74 | 0.150 |
Why?
| | Axons | 2 | 2018 | 205 | 0.140 |
Why?
| | Mice, Transgenic | 6 | 2016 | 2131 | 0.140 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 302 | 0.140 |
Why?
| | Cofilin 1 | 1 | 2018 | 5 | 0.140 |
Why?
| | Oligosaccharides | 1 | 2019 | 61 | 0.140 |
Why?
| | Mutagenesis | 1 | 2019 | 196 | 0.140 |
Why?
| | Corpus Callosum | 1 | 2019 | 76 | 0.140 |
Why?
| | Calcineurin | 1 | 2019 | 105 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 175 | 0.140 |
Why?
| | Drug Design | 1 | 2019 | 179 | 0.140 |
Why?
| | Protein Aggregation, Pathological | 1 | 2018 | 22 | 0.140 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 561 | 0.140 |
Why?
| | Nerve Net | 1 | 2021 | 284 | 0.140 |
Why?
| | Thalamic Nuclei | 1 | 2018 | 10 | 0.140 |
Why?
| | Holoenzymes | 1 | 2018 | 25 | 0.140 |
Why?
| | Pre-Eclampsia | 1 | 2020 | 206 | 0.140 |
Why?
| | Interleukin-10 | 3 | 2015 | 310 | 0.130 |
Why?
| | Biomedical Research | 1 | 2024 | 724 | 0.130 |
Why?
| | Receptor, trkB | 1 | 2018 | 39 | 0.130 |
Why?
| | Lateral Ventricles | 1 | 2018 | 32 | 0.130 |
Why?
| | Myelin Proteolipid Protein | 1 | 2018 | 61 | 0.130 |
Why?
| | Membrane Proteins | 2 | 2021 | 1130 | 0.130 |
Why?
| | Heparin | 1 | 2019 | 246 | 0.130 |
Why?
| | Alloxan | 1 | 1997 | 4 | 0.130 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 11 | 0.130 |
Why?
| | Molecular Dynamics Simulation | 1 | 2019 | 267 | 0.130 |
Why?
| | Receptors, Glutamate | 1 | 2016 | 26 | 0.120 |
Why?
| | Cerebral Arteries | 1 | 2017 | 56 | 0.120 |
Why?
| | Glutathione | 1 | 1999 | 369 | 0.120 |
Why?
| | Mitochondria | 2 | 2021 | 996 | 0.120 |
Why?
| | Gene Knockdown Techniques | 2 | 2020 | 334 | 0.120 |
Why?
| | Leukoencephalopathies | 1 | 2016 | 23 | 0.120 |
Why?
| | Actins | 1 | 2018 | 422 | 0.120 |
Why?
| | Dementia | 1 | 2020 | 322 | 0.120 |
Why?
| | Cations | 3 | 2003 | 83 | 0.120 |
Why?
| | Pericytes | 1 | 2016 | 42 | 0.120 |
Why?
| | Spleen | 3 | 2015 | 503 | 0.120 |
Why?
| | Furans | 1 | 2015 | 26 | 0.110 |
Why?
| | Collagen Type I | 1 | 2016 | 144 | 0.110 |
Why?
| | Inflammation | 4 | 2021 | 2915 | 0.110 |
Why?
| | Tretinoin | 1 | 2016 | 114 | 0.110 |
Why?
| | Cell Communication | 2 | 2016 | 327 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2013 | 333 | 0.110 |
Why?
| | Transfection | 2 | 2016 | 914 | 0.110 |
Why?
| | Arginase | 1 | 2015 | 26 | 0.110 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 249 | 0.110 |
Why?
| | Interleukin-1beta | 2 | 2014 | 394 | 0.110 |
Why?
| | Membrane Potentials | 5 | 1999 | 278 | 0.110 |
Why?
| | Calbindins | 1 | 2014 | 6 | 0.110 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2014 | 30 | 0.110 |
Why?
| | Neutrophil Activation | 1 | 2015 | 84 | 0.110 |
Why?
| | Dizocilpine Maleate | 1 | 2014 | 24 | 0.110 |
Why?
| | Brain Concussion | 1 | 2023 | 660 | 0.110 |
Why?
| | Calcium Channel Agonists | 1 | 2014 | 12 | 0.110 |
Why?
| | Trauma, Nervous System | 1 | 2014 | 3 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 2 | 2013 | 277 | 0.100 |
Why?
| | Tissue Culture Techniques | 1 | 2014 | 82 | 0.100 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2014 | 108 | 0.100 |
Why?
| | Microinjections | 2 | 2011 | 92 | 0.100 |
Why?
| | Nerve Tissue Proteins | 2 | 2016 | 594 | 0.100 |
Why?
| | Mutation | 2 | 2020 | 4082 | 0.100 |
Why?
| | Lentivirus | 2 | 2011 | 61 | 0.100 |
Why?
| | Quinolines | 1 | 2015 | 191 | 0.100 |
Why?
| | CD40 Antigens | 1 | 2014 | 67 | 0.100 |
Why?
| | Analysis of Variance | 3 | 2015 | 1293 | 0.100 |
Why?
| | Aortic Diseases | 1 | 2015 | 124 | 0.100 |
Why?
| | Aged | 6 | 2025 | 26251 | 0.100 |
Why?
| | Practice Guidelines as Topic | 1 | 2022 | 1581 | 0.100 |
Why?
| | Cross Infection | 1 | 2016 | 258 | 0.100 |
Why?
| | Arachidonic Acids | 1 | 2013 | 42 | 0.100 |
Why?
| | Immunophenotyping | 1 | 2014 | 324 | 0.100 |
Why?
| | Body Temperature | 1 | 2014 | 227 | 0.090 |
Why?
| | Embryo, Mammalian | 1 | 2013 | 230 | 0.090 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 53 | 0.090 |
Why?
| | Piperidines | 1 | 2014 | 223 | 0.090 |
Why?
| | Electroencephalography | 1 | 2016 | 570 | 0.090 |
Why?
| | Immune Tolerance | 1 | 2015 | 384 | 0.090 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2013 | 199 | 0.090 |
Why?
| | Glomerular Filtration Barrier | 1 | 2012 | 1 | 0.090 |
Why?
| | Ovariectomy | 3 | 2025 | 164 | 0.090 |
Why?
| | Polymerase Chain Reaction | 3 | 2012 | 1030 | 0.090 |
Why?
| | Testosterone | 3 | 2010 | 419 | 0.090 |
Why?
| | RNA, Small Interfering | 2 | 2011 | 630 | 0.090 |
Why?
| | Endothelium | 1 | 2012 | 119 | 0.090 |
Why?
| | Microscopy, Immunoelectron | 1 | 2011 | 38 | 0.090 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 66 | 0.080 |
Why?
| | Up-Regulation | 2 | 2025 | 840 | 0.080 |
Why?
| | Culture Media | 1 | 2011 | 160 | 0.080 |
Why?
| | Iraq War, 2003-2011 | 2 | 2023 | 163 | 0.080 |
Why?
| | Pyramidal Cells | 1 | 2011 | 80 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2014 | 311 | 0.080 |
Why?
| | Afghan Campaign 2001- | 2 | 2023 | 182 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2022 | 11744 | 0.080 |
Why?
| | Biomarkers | 2 | 2025 | 4329 | 0.080 |
Why?
| | Child | 4 | 2019 | 22638 | 0.080 |
Why?
| | Cell Line | 5 | 2012 | 2809 | 0.080 |
Why?
| | Isoflurane | 1 | 2010 | 41 | 0.080 |
Why?
| | United States | 3 | 2023 | 16041 | 0.080 |
Why?
| | Retrospective Studies | 7 | 2023 | 17291 | 0.080 |
Why?
| | Genetic Vectors | 1 | 2011 | 326 | 0.080 |
Why?
| | Anesthetics, Inhalation | 1 | 2010 | 52 | 0.080 |
Why?
| | Cell Movement | 1 | 2014 | 950 | 0.080 |
Why?
| | Motor Activity | 2 | 2011 | 701 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1041 | 0.070 |
Why?
| | Ischemic Attack, Transient | 1 | 2010 | 71 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 662 | 0.070 |
Why?
| | Disease Progression | 1 | 2017 | 2857 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2018 | 2783 | 0.070 |
Why?
| | Aged, 80 and over | 4 | 2025 | 8351 | 0.070 |
Why?
| | Neutrophils | 1 | 2015 | 1132 | 0.070 |
Why?
| | Pregnancy | 3 | 2020 | 7217 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 899 | 0.070 |
Why?
| | Apoptosis | 3 | 2016 | 2436 | 0.060 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2011 | 676 | 0.060 |
Why?
| | Risk Assessment | 3 | 2025 | 3678 | 0.060 |
Why?
| | Animals, Newborn | 2 | 2023 | 887 | 0.060 |
Why?
| | Kidney | 2 | 2012 | 1491 | 0.060 |
Why?
| | In Situ Nick-End Labeling | 1 | 2006 | 120 | 0.060 |
Why?
| | Menopause | 1 | 2010 | 327 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2014 | 861 | 0.060 |
Why?
| | Muscle Denervation | 2 | 2002 | 8 | 0.060 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2006 | 50 | 0.060 |
Why?
| | Tumor Cells, Cultured | 2 | 1997 | 878 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2010 | 427 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2011 | 884 | 0.060 |
Why?
| | Cyclic Nucleotide-Gated Cation Channels | 1 | 2004 | 15 | 0.050 |
Why?
| | Electrophysiology | 3 | 2003 | 219 | 0.050 |
Why?
| | Decorin | 1 | 2023 | 7 | 0.050 |
Why?
| | Infarction | 1 | 2023 | 9 | 0.050 |
Why?
| | Hospital Mortality | 2 | 2021 | 1037 | 0.050 |
Why?
| | Chondroitin Sulfates | 1 | 2023 | 35 | 0.050 |
Why?
| | Cyclic AMP | 1 | 2004 | 208 | 0.050 |
Why?
| | Kv1.1 Potassium Channel | 1 | 2003 | 8 | 0.050 |
Why?
| | Carbonic Anhydrases | 1 | 2003 | 12 | 0.050 |
Why?
| | Genes, Lethal | 1 | 2003 | 29 | 0.050 |
Why?
| | Middle Aged | 5 | 2025 | 36359 | 0.050 |
Why?
| | Shal Potassium Channels | 1 | 2003 | 5 | 0.050 |
Why?
| | Acetazolamide | 1 | 2003 | 26 | 0.050 |
Why?
| | Fasciculation | 1 | 2002 | 2 | 0.050 |
Why?
| | Rats, Wistar | 2 | 2017 | 449 | 0.050 |
Why?
| | Iraq | 1 | 2023 | 66 | 0.050 |
Why?
| | Spatial Memory | 1 | 2022 | 27 | 0.050 |
Why?
| | Afghanistan | 1 | 2023 | 96 | 0.050 |
Why?
| | Databases, Factual | 2 | 2021 | 1481 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 156 | 0.050 |
Why?
| | Risk Factors | 3 | 2025 | 10840 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 441 | 0.040 |
Why?
| | Tolbutamide | 2 | 1999 | 5 | 0.040 |
Why?
| | Models, Neurological | 1 | 2004 | 252 | 0.040 |
Why?
| | Muscular Diseases | 1 | 2002 | 110 | 0.040 |
Why?
| | Fibrin Clot Lysis Time | 1 | 2021 | 10 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2014 | 438 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2002 | 1795 | 0.040 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 2 | 2011 | 53 | 0.040 |
Why?
| | Self Administration | 1 | 2021 | 121 | 0.040 |
Why?
| | Adoptive Transfer | 2 | 2011 | 197 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 221 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2003 | 292 | 0.040 |
Why?
| | Aorta, Thoracic | 2 | 2013 | 284 | 0.040 |
Why?
| | Tumor Necrosis Factors | 1 | 2020 | 10 | 0.040 |
Why?
| | Inflammation Mediators | 2 | 2013 | 507 | 0.040 |
Why?
| | Swine | 1 | 2023 | 821 | 0.040 |
Why?
| | Nucleus Accumbens | 1 | 2021 | 135 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2001 | 214 | 0.040 |
Why?
| | Neurotoxins | 1 | 2020 | 28 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2003 | 449 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2020 | 244 | 0.040 |
Why?
| | Air Ambulances | 1 | 2020 | 56 | 0.040 |
Why?
| | Thapsigargin | 1 | 1999 | 20 | 0.040 |
Why?
| | Dendritic Spines | 1 | 2020 | 70 | 0.040 |
Why?
| | Cesium | 1 | 1999 | 20 | 0.040 |
Why?
| | Ion Transport | 1 | 1999 | 61 | 0.040 |
Why?
| | Lymph Nodes | 2 | 2011 | 511 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2003 | 1236 | 0.030 |
Why?
| | Recurrence | 1 | 2021 | 1125 | 0.030 |
Why?
| | Barium | 1 | 1997 | 27 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2020 | 255 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2019 | 246 | 0.030 |
Why?
| | Thiourea | 1 | 1997 | 41 | 0.030 |
Why?
| | Magnesium | 1 | 1997 | 155 | 0.030 |
Why?
| | Kinetics | 2 | 1997 | 1553 | 0.030 |
Why?
| | Free Radical Scavengers | 1 | 1997 | 81 | 0.030 |
Why?
| | Oligopeptides | 1 | 1999 | 264 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2018 | 266 | 0.030 |
Why?
| | Exons | 1 | 2018 | 361 | 0.030 |
Why?
| | Resuscitation | 1 | 2020 | 314 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 388 | 0.030 |
Why?
| | Inpatients | 1 | 2021 | 538 | 0.030 |
Why?
| | Protein Transport | 1 | 2018 | 439 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2016 | 47 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2016 | 103 | 0.030 |
Why?
| | Niacinamide | 1 | 1997 | 103 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2016 | 92 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 314 | 0.030 |
Why?
| | Glucose Transporter Type 1 | 1 | 2016 | 49 | 0.030 |
Why?
| | Seizures | 1 | 2020 | 489 | 0.030 |
Why?
| | Cell Polarity | 1 | 1997 | 137 | 0.030 |
Why?
| | Biological Transport | 1 | 2017 | 423 | 0.030 |
Why?
| | Cytokines | 2 | 2014 | 2079 | 0.030 |
Why?
| | Heme Oxygenase-1 | 1 | 2016 | 76 | 0.030 |
Why?
| | Stromal Cells | 1 | 2016 | 123 | 0.030 |
Why?
| | Hypoxia | 2 | 2014 | 1209 | 0.030 |
Why?
| | Cysteine | 1 | 1997 | 210 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2017 | 172 | 0.030 |
Why?
| | Receptors, Estrogen | 2 | 2012 | 405 | 0.030 |
Why?
| | Estrogen Receptor alpha | 2 | 2010 | 154 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 240 | 0.030 |
Why?
| | Adult | 2 | 2021 | 40821 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 22451 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 876 | 0.030 |
Why?
| | Blood Vessels | 1 | 2016 | 164 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 1997 | 494 | 0.030 |
Why?
| | Neurologic Examination | 1 | 2015 | 129 | 0.030 |
Why?
| | T-Lymphocytes | 2 | 2015 | 2007 | 0.030 |
Why?
| | Nanostructures | 1 | 2016 | 104 | 0.030 |
Why?
| | Hindlimb | 1 | 2015 | 128 | 0.030 |
Why?
| | Colorado | 1 | 2025 | 4588 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1824 | 0.030 |
Why?
| | California | 1 | 2016 | 473 | 0.030 |
Why?
| | Locomotion | 1 | 2015 | 102 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 1997 | 610 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2014 | 195 | 0.030 |
Why?
| | Hematoxylin | 1 | 2013 | 8 | 0.030 |
Why?
| | Eosine Yellowish-(YS) | 1 | 2013 | 10 | 0.030 |
Why?
| | Fluoresceins | 1 | 2013 | 48 | 0.020 |
Why?
| | Constriction | 1 | 2013 | 45 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2003 | 2591 | 0.020 |
Why?
| | Arginine | 1 | 2015 | 263 | 0.020 |
Why?
| | Chalcones | 1 | 2013 | 7 | 0.020 |
Why?
| | Movement | 1 | 2016 | 290 | 0.020 |
Why?
| | CREB-Binding Protein | 1 | 2013 | 34 | 0.020 |
Why?
| | Protein Binding | 1 | 2020 | 2239 | 0.020 |
Why?
| | Odds Ratio | 1 | 2016 | 1070 | 0.020 |
Why?
| | Cohort Studies | 1 | 2024 | 6045 | 0.020 |
Why?
| | Ligation | 1 | 2013 | 88 | 0.020 |
Why?
| | Apamin | 2 | 2004 | 4 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2013 | 252 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1531 | 0.020 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2012 | 34 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 237 | 0.020 |
Why?
| | Hypoglycemic Agents | 2 | 1999 | 1411 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2097 | 0.020 |
Why?
| | Fibronectins | 1 | 2012 | 136 | 0.020 |
Why?
| | Kidney Glomerulus | 1 | 2012 | 129 | 0.020 |
Why?
| | Proteins | 1 | 1997 | 1021 | 0.020 |
Why?
| | Lymphocyte Subsets | 1 | 2011 | 79 | 0.020 |
Why?
| | Receptors, CCR7 | 1 | 2011 | 32 | 0.020 |
Why?
| | Comorbidity | 1 | 2016 | 1652 | 0.020 |
Why?
| | Receptors, CCR5 | 1 | 2011 | 59 | 0.020 |
Why?
| | Logistic Models | 1 | 2016 | 2112 | 0.020 |
Why?
| | Mice, SCID | 1 | 2011 | 360 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2011 | 105 | 0.020 |
Why?
| | Blood | 1 | 2011 | 107 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2010 | 87 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 423 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2011 | 415 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 340 | 0.020 |
Why?
| | Kidney Cortex | 1 | 2010 | 27 | 0.020 |
Why?
| | Aromatase | 1 | 2010 | 37 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2010 | 53 | 0.020 |
Why?
| | Acute-Phase Proteins | 1 | 2010 | 66 | 0.020 |
Why?
| | Lipocalins | 1 | 2010 | 35 | 0.020 |
Why?
| | Exploratory Behavior | 1 | 2010 | 86 | 0.020 |
Why?
| | Estrogen Receptor beta | 1 | 2010 | 40 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2013 | 861 | 0.020 |
Why?
| | Aromatase Inhibitors | 1 | 2010 | 81 | 0.020 |
Why?
| | Oncogene Proteins | 1 | 2010 | 61 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2013 | 473 | 0.020 |
Why?
| | Renal Circulation | 1 | 2010 | 75 | 0.020 |
Why?
| | Lipocalin-2 | 1 | 2010 | 80 | 0.020 |
Why?
| | Castration | 1 | 2009 | 11 | 0.020 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 109 | 0.020 |
Why?
| | Androgen Receptor Antagonists | 1 | 2009 | 35 | 0.020 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2010 | 218 | 0.020 |
Why?
| | Androgen Antagonists | 1 | 2009 | 91 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1223 | 0.020 |
Why?
| | Creatinine | 1 | 2010 | 511 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5397 | 0.020 |
Why?
| | Wound Healing | 1 | 2010 | 348 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1160 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 727 | 0.010 |
Why?
| | Autoimmunity | 1 | 2011 | 924 | 0.010 |
Why?
| | Pediatrics | 1 | 2013 | 1122 | 0.010 |
Why?
| | Infant | 1 | 2018 | 10093 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14240 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2004 | 317 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11888 | 0.010 |
Why?
| | Evoked Potentials | 1 | 2004 | 132 | 0.010 |
Why?
| | Blood Pressure | 1 | 2010 | 1761 | 0.010 |
Why?
| | COS Cells | 1 | 2003 | 173 | 0.010 |
Why?
| | Intracellular Membranes | 1 | 2003 | 76 | 0.010 |
Why?
| | Myoblasts | 1 | 2003 | 83 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2003 | 273 | 0.010 |
Why?
| | Sarcoplasmic Reticulum | 1 | 2001 | 37 | 0.010 |
Why?
| | Egtazic Acid | 1 | 2001 | 37 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 190 | 0.010 |
Why?
| | Cobalt | 1 | 2001 | 50 | 0.010 |
Why?
| | Chelating Agents | 1 | 2001 | 75 | 0.010 |
Why?
| | Potassium | 1 | 2001 | 151 | 0.010 |
Why?
| | Calcium Channels | 1 | 2001 | 157 | 0.010 |
Why?
| | Electromyography | 1 | 2002 | 417 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2002 | 427 | 0.010 |
Why?
| | Base Sequence | 1 | 2003 | 2119 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2835 | 0.010 |
Why?
| | Biotransformation | 1 | 1997 | 61 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2003 | 1429 | 0.010 |
Why?
| | Leptin | 1 | 1997 | 247 | 0.010 |
Why?
| | Xenopus laevis | 1 | 1996 | 101 | 0.010 |
Why?
| | Potassium Channel Blockers | 1 | 1996 | 47 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 1996 | 205 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 326 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 487 | 0.010 |
Why?
| | Oocytes | 1 | 1996 | 186 | 0.010 |
Why?
|
|
Herson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|